Research Paper Volume 13, Issue 15 pp 19575—19586

Plasmatic exosome-derived circRNAs panel act as fingerprint for glioblastoma

class="figure-viewer-img"

Figure 2. Validation of three candidate circRNAs. Plasma from 100 paired GBM and healthy controls were enrolled. Data were presented as plot of the median and range of log-transformed relative expression level. * indicated p<0.05; ** indicated p < 0.01, n.s. indicated no significance.